10 Best Healthcare Executives Transforming 2026

Clinical breakthroughs and hospital infrastructure are no longer enough to define modern healthcare. Today, the industry is shaped by the intersection of innovation, accessibility, and patient trust. TradeFlock’s latest edition, “10 Best Healthcare Executives Transforming 2026,” profiles the leaders driving this transformation and the vision guiding their organizations.

During the development of this edition, we interviewed healthcare leaders serving as Chief Medical Officers, Senior Medical Directors, Clinical Directors, CEOs, and senior executives across hospitals, biotechnology, pharmaceuticals, and digital health. While their specialities and geographies differ, they share a deep sense of responsibility toward the people they serve.

In this edition, you will discover candid interviews, leadership insights, and the strategic decisions shaping the work of some of the world’s most influential healthcare organizations. This issue also features our Story of the Month, Behind the Ongoing Heatwave in the US: A Combination of Heat Dome and Climate Change.

Yann A. Meunier, MD

Director - International Institute of Medicine and Science and Former CEO of Health Connect International, LLC

An international healthcare executive and physician with 25 years of experience spanning Europe, Asia, Africa, Oceania, and the Americas, he seamlessly bridges frontline tropical medicine with corporate health strategies. Having managed public health operations and served in roles ranging from primary care physician to Chief Medical Officer, he brings a breadth of experience that lends depth and authenticity to every endeavor.

Dr. Amy Flaster

Chief Medical Officer

Cigna Healthcare

With a profound expertise in internal medicine and senior care, Dr Amy Flaster from The Cigna Group serves as CMO. Her leadership at ConcertoCare has strengthened her ability to bridge traditional clinical practice with digital health innovation, offering a unique perspective on technology-driven, value-based, and integrated whole-person healthcare models.

Daniel Gandia

Senior Medical Director, Oncology

Fortrea

Senior Medical Director at Fortrea with more than 30 years of experience in clinical oncology and pharmaceutical research, Daniel Gandia specializes in early-phase oncology trials and the evaluation of innovative drugs. Pioneered the European Phase I development of Irinotecan, known for identifying its acute cholinergic syndrome and establishing the high-dose loperamide protocol for managing delayed diarrhea.

Graham Rosenberg

Founder & CEO

Dentalcorp

With a deep background in private equity and corporate finance, Graham Rosenberg, a CPA-trained founder and CEO of Dentalcorp, effectively bridges the gap between business scale and clinical autonomy. His innovative approach removes administrative burdens, allowing dentists to concentrate entirely on patient care. This operating model not only enhances their practice experience but also plays a pivotal role in optimizing healthcare delivery across Canada.

Jerry Creech

SVP

Flip AI

Jerry Creech is known for leading strategic healthcare partnerships, drawing on over 20 years of operational and financial expertise to expand Flip’s purpose-built voice AI platform in the healthcare sector. This innovative technology by Jerry Creech is designed to address common phone-based administrative challenges, recover lost revenue associated with missed patient interactions, and reduce operational costs, all while seamlessly integrating into existing workflows to create a more efficient and patient-centric experience.

John Rim

Board Chair & CEO

Samsung Biologics

With over 30 years of premier global biopharma expertise stemming from Roche and Genentech, John Rim plays a vital role at Samsung Biologics. His expertise in large-scale biopharmaceutical manufacturing helps address the industry’s manufacturing capacity gap. This unique combination drives the company’s evolution into a highly sustainable global CDMO leader.

Justine Paula Nichol

Clinical Director

Veiros Ltd.

Clinical doctoral candidate and Advanced Nurse Practitioner with senior leadership in pharmaceutical medical affairs, sales management, and training, Justine Paula Nichol brings deep therapeutic expertise across Oncology, Cardiovascular, and Respiratory sectors. She holds an MSc from the University of Stirling while bridging clinical excellence and commercial strategy.

Dr. Majid Al-Fayyadh

CEO

King Faisal Specialist Hospital and Research Centre (KFSHRC)

With a passion for advancing pediatric cardiology and electrophysiology, Dr Majid Al-Fayyadh, CEO of KFSHRC, combines his medical expertise with a Master’s in Medical Management. He brings extensive experience in clinical practice and policy advisory roles to actively foster innovation in biotechnology and institutional development, aligning with the visionary goals of Saudi Vision 2030.

Robert J. White

President & CEO

Olympus Corporation

With over 30 years of leadership experience spanning Asia, Europe, and the US, Robert J. White, President and CEO of Olympus, brings a deep understanding of global healthcare and technology. His commitment to building diverse, high-performing teams is matched by a disciplined approach to execution, focused on addressing evolving clinical challenges.

Sonya Lockyer

President & CEO

Lifemark Health Group

From humble beginnings in rural Newfoundland to serving in the military, the President & CEO of Lifemark Health Group has been shaped by leadership. She champions a bold mission, “Movement to a better life”, focused on building Canada’s Connected Health Network. Firm, fair, and purpose-driven, she inspires and empowers elite teams to expand healthcare access, creating a more connected and compassionate health system that truly makes a difference.